In this webinar, our molecular leaders, Dr. Rafal Iwasiow and Scott Rabuka provide examples of collection solutions and testing strategies being deployed for COVID-19 detection and insights into the future of testing and surveillance as we navigate SARS-CoV-2 variants and the deployment of vaccines.
Watch this panel discussion, where our speakers, along with special guest Richard Uhlig, Founder & CEO of Quadrant Biosciences, explore practical advice of current testing trends with, real-world examples of how Quadrant has implemented innovative testing strategies for COVID-19.
